By Dr. Chinta Sidharthan Review explores the connection between gene length and aging, summarizing recent findings that link ...

Six-year-old Cooper Wood was diagnosed with Duchenne muscular dystrophy earlier this year. When his parents applied for a one ...

Six-year-old Cooper Wood was diagnosed with Duchenne muscular dystrophy earlier this year. When his parents applied for a one ...

DMD is a progressive muscle disease due to muscle degeneration leading to severe physical disability and shortened lifespan.

Michelle C. Werner agonized over whether the gene therapy treatment Elevidys was right for her teenage son. But to him, the ...

On September 06, 2024, GenAssist Ltd (GenAssist), announced the first DMD patient dosed with its base editing drug, GEN6050X injection, in an investigator-initiated trial (IIT). "This is the ...

A possible gene therapy approval and a series of major trials readouts set the stage for a busy year of drug development in Duchenne muscular dystrophy.

Sarepta's Elevidys approval, revenue growth projections, and competitive position make it a strong investment in DMD ...

Satellos Bioscience Inc. ("Satellos" or the "Company") (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle ...

Dyne Therapeutics, Inc. saw a huge stock surge and subsequent drop, leaving investors wondering about a potential buying ...

Longford man Gerard Sheehan, who is the Director of Global Medical Affairs at Sarepta Therapeutics, is celebrating this week ...

Nationwide Children's Hospital has renamed its gene therapy research program and clinics for Dr. Jerry Mendell, who devoted ...